Derna Palmisano
Overview
Explore the profile of Derna Palmisano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
0
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pelizza L, Federico A, Leuci E, Quattrone E, Palmisano D, Pupo S, et al.
Eur Arch Psychiatry Clin Neurosci
. 2025 Mar;
PMID: 40045056
The PANSS Autism Severity Score (PAUSS) is a popular measure of autistic features in First Episode Psychosis (FEP) samples. However, evidence on its longitudinal stability, course and treatment response is...
2.
Pelizza L, Catalano F, Leuci E, Quattrone E, Palmisano D, Pupo S, et al.
Eur Arch Psychiatry Clin Neurosci
. 2025 Feb;
PMID: 40021518
Examining psychiatric antecedents and help-seeking behavior for people with First Episode Psychosis (FEP) could help understand determinants for timely care pathways, decrease the "Duration of Untreated Psychosis" (DUP), and consequently...
3.
Pelizza L, Ricci C, Leuci E, Quattrone E, Palmisano D, Pupo S, et al.
Arch Womens Ment Health
. 2025 Feb;
PMID: 39971780
Purpose: Males and females with First Episode Psychosis (FEP) usually tend to differ in psychopathology, clinical presentation and their longitudinal trajectory. This study aimed to examine the difference of effectiveness...
4.
Pelizza L, Di Lisi A, Leuci E, Quattrone E, Palmisano D, Pupo S, et al.
Hum Psychopharmacol
. 2025 Feb;
40(2):e70003.
PMID: 39962036
Objective: Despite various models examining baseline factors, predicting outcomes in individuals at clinical high risk for psychosis (CHR-P) remains challenging. Specifically, neglecting factors like ongoing antipsychotic (AP) medications introduce bias...
5.
Pelizza L, Di Lisi A, Leuci E, Quattrone E, Palmisano D, Pellegrini C, et al.
Suicide Life Threat Behav
. 2024 Oct;
55(1):e13136.
PMID: 39425541
Introduction: Suicidal ideation has high rates among individuals at Clinical High Risk for Psychosis (CHR-P). CHR-P mental states are currently defined as attenuated psychotic symptoms, brief intermittent psychotic symptoms, or...
6.
Catalano F, Leuci E, Quattrone E, Palmisano D, Pellegrini P, Pupo S, et al.
Early Interv Psychiatry
. 2024 Jul;
19(1):e13599.
PMID: 39034609
Aims: Since there are few studies on this topic, the goals of this examination were: (1) to calculate service disengagement rates in a CHR-P sample along 2-years of follow-up; and...
7.
Ricci C, Leuci E, Quattrone E, Palmisano D, Pellegrini P, Menchetti M, et al.
Eur Arch Psychiatry Clin Neurosci
. 2024 Apr;
274(6):1311-1326.
PMID: 38668766
Negative symptoms in CHR-P people are generally not responsive to treatments and commonly related to poorer functional outcome. However, less research attention has been dedicated to Persistent Negative Symptoms (PNS),...
8.
Palmisano D, Varesi D, Taurino M, Scarci M, Mammone E, Rancati S, et al.
J Patient Exp
. 2022 Feb;
8:23743735211043375.
PMID: 35187220
No abstract available.
9.
Pelizza L, Zaimovic A, Veneri B, Urbani B, Cutrino S, Gran DallOlio D, et al.
Acta Biomed
. 2021 Jul;
92(3):e2021223.
PMID: 34212919
Background - Interventions for inmates with Pathological Addiction (PA) still remain a problematic issue in Italian prisons, despite a 1999 major government reform transferring PA care in prison to the...